Fidelity Investments’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$93.8M Sell
1,929,154
-11,391
-0.6% -$554K 0.01% 1147
2025
Q1
$66M Sell
1,940,545
-282,748
-13% -$9.62M ﹤0.01% 1262
2024
Q4
$87.5M Sell
2,223,293
-152,873
-6% -$6.02M 0.01% 1176
2024
Q3
$112M Buy
2,376,166
+23,075
+1% +$1.08M 0.01% 1058
2024
Q2
$127M Buy
2,353,091
+113,408
+5% +$6.13M 0.01% 960
2024
Q1
$153M Buy
2,239,683
+399,812
+22% +$27.3M 0.01% 896
2023
Q4
$115M Sell
1,839,871
-217,543
-11% -$13.6M 0.01% 959
2023
Q3
$93.4M Sell
2,057,414
-33,759
-2% -$1.53M 0.01% 1000
2023
Q2
$117M Sell
2,091,173
-47,883
-2% -$2.69M 0.01% 920
2023
Q1
$96.7M Sell
2,139,056
-45,328
-2% -$2.05M 0.01% 997
2022
Q4
$88.8M Buy
2,184,384
+37,940
+2% +$1.54M 0.01% 1017
2022
Q3
$140M Buy
2,146,444
+527,422
+33% +$34.5M 0.01% 820
2022
Q2
$98.4M Buy
1,619,022
+357,400
+28% +$21.7M 0.01% 980
2022
Q1
$79.2M Buy
1,261,622
+890,900
+240% +$55.9M 0.01% 1182
2021
Q4
$28.1M Sell
370,722
-203,759
-35% -$15.4M ﹤0.01% 1662
2021
Q3
$64.3M Sell
574,481
-2,246
-0.4% -$251K 0.01% 1310
2021
Q2
$93.4M Buy
576,727
+8,805
+2% +$1.43M 0.01% 1148
2021
Q1
$69.2M Sell
567,922
-339,867
-37% -$41.4M 0.01% 1238
2020
Q4
$139M Sell
907,789
-40,664
-4% -$6.23M 0.01% 892
2020
Q3
$79.3M Sell
948,453
-93,357
-9% -$7.81M 0.01% 1018
2020
Q2
$76.6M Buy
1,041,810
+164,796
+19% +$12.1M 0.01% 988
2020
Q1
$37.2M Sell
877,014
-75,355
-8% -$3.2M 0.01% 1142
2019
Q4
$58M Buy
952,369
+398,012
+72% +$24.2M 0.01% 1144
2019
Q3
$22.7M Buy
554,357
+256,088
+86% +$10.5M ﹤0.01% 1524
2019
Q2
$14M Buy
298,269
+55,933
+23% +$2.63M ﹤0.01% 1763
2019
Q1
$8.66M Sell
242,336
-73,500
-23% -$2.63M ﹤0.01% 1915
2018
Q4
$9.02M Buy
315,836
+16,900
+6% +$483K ﹤0.01% 1837
2018
Q3
$13.3M Buy
298,936
+101,028
+51% +$4.48M ﹤0.01% 1847
2018
Q2
$11.6M Buy
+197,908
New +$11.6M ﹤0.01% 1904